NWS
81
-2
MRO
46
3
DG
30
6
USB
43
-3
VRTX
69
4
SPG
68
4
NDAQ
49
-3
D
51
3
CF
29
2
RCL
70
-2
ADM
44
5
DOW
56
2
NWL
43
2
SYK
60
5
MAC
70
3
DFS
59
-5
SWKS
42
2
ITW
64
3
KIM
50
-3
SNA
62
2
NWS
81
-2
MRO
46
3
DG
30
6
USB
43
-3
VRTX
69
4
SPG
68
4
NDAQ
49
-3
D
51
3
CF
29
2
RCL
70
-2
ADM
44
5
DOW
56
2
NWL
43
2
SYK
60
5
MAC
70
3
DFS
59
-5
SWKS
42
2
ITW
64
3
KIM
50
-3
SNA
62
2
Financhill
Back

Sonoma Pharmaceuticals 10K Form

Sell
24

SNOA
Sonoma Pharmaceuticals

Last Price:
0.16
Seasonality Move:
2.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SNOA News And Ratings

See the #1 stock for the next 7 days that we like better than SNOA

SNOA Financial Statistics

Sales & Book Value

Annual Sales: $13.27M
Cash Flow: $-1.11M
Price / Cash Flow: 0
Annual Sales: $0.49
Price / Book: 0.35

Profitability

EPS (TTM): -0.94000
Net Income (TTM): $-5.08M
Gross Margin: $4.48M
Return on Equity: -76.57%
Return on Assets: -34.16%

Sonoma Pharmaceuticals Earnings Forecast

Key Sonoma Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for SNOA is 33.73%.
  • The Selling, General & Administrative Expenses for SNOA have been equal to 66.61% of Gross Profit Margin.
  • The Research & Development expenses have been 1.56% of Revenue.
  • The Interest Expense is -0.25% of Operating Income.
  • The Net Earning history of SNOA is -38.81% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 15 years.

Sonoma Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SNOA
CUSIP: 83558L
Website: sonomapharma.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 4.07
Quick Ratio: 1.72

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SNOA Technical Analysis vs Fundamental Analysis

Sell
24
Sonoma Pharmaceuticals (SNOA) is a Sell

Is Sonoma Pharmaceuticals a Buy or a Sell?